Clinical Trial Update: Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.

View source ↗

Summary

This document provides an update on an individual patient expanded access IND using HB-adMSCs for chronic pain, noting that the program is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• HB-adMSCs (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences Research Foundation | Conditions: Chronic Pain | Status: NO_LONGER_AVAILABLE